Suche

43472 Ergebnisse
Assessment_report_of_CHMP_date_161013.pdf
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website
18.12.2017 Datei PD
Annex_2-Scientific_conclusion_first_published_161221.pdf
Annex II Scientific conclusions Scientific conclusions Metformin, alone or in combination with other medicines, is considered the first choice in the treatment for Type 2 diabetes mellit
18.12.2017 Datei PD
CHMP_List_of_questions_date_160128.pdf
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website
18.12.2017 Datei PD
Notification_date_160125.pdf
18.12.2017 Datei PD
Personalwechsel im Bundesministerium für Gesundheit
Wie heute aus der Leitungsebene des Bundesministeriums für Gesundheit (BMG) bekanntgegeben wurde, wird es auf der Ebene zweier Abteilungsleitungen Wechsel geben. Demnach wird die derzeitige Leiterin d
18.12.2017 Meldung PD
Recommendation_date_161212.pdf
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website
18.12.2017 Datei PD
Annex_3-Changes_to_the_summary_of_product_characteristics_first_published_161221.pdf
Annex III Amendments to relevant sections of the Product Information Note: These amendments to the relevant sections of the Product Information are the outcome of the referral procedure.
18.12.2017 Datei PD
Questions_and_answers_on_the_review_date_090122.pdf
European Medicines Agency 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea.europa.eu http://www.emea.europa.eu
18.12.2017 Datei PD
Annex_1-4__first_published_070714.pdf
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES (EU/EEA) 1 Marketing
18.12.2017 Datei PD
CHMP_recommendation_date_090122.pdf
Elements recommended for inclusion in Summaries of Product Characteristics for methylphenidate-containing medicinal products authorised for the treatment of ADHD in children aged six years and abov
18.12.2017 Datei PD
Zeichenfläche 1